TMS Neuro Solutions Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Healthcare

Industry

Estimated Revenue & Valuation

  • TMS Neuro Solutions's estimated annual revenue is currently $24.3M per year.(i)
  • TMS Neuro Solutions's estimated revenue per employee is $270,000

Employee Data

  • TMS Neuro Solutions has 90 Employees.(i)
  • TMS Neuro Solutions grew their employee count by 0% last year.

TMS Neuro Solutions's People

NameTitleEmail/Phone
1
VP People EngagementReveal Email/Phone
2
Director TMS CareReveal Email/Phone
3
Chief Reporting OfficerReveal Email/Phone
4
Director Patient AdvocacyReveal Email/Phone
5
Texas Clinical DirectorReveal Email/Phone
6
Director IT ServicesReveal Email/Phone
7
Clinical Excellence DirectorReveal Email/Phone
8
IT ManagerReveal Email/Phone
9
Treatment Coordinator ManagerReveal Email/Phone
10
Treatment Coordinator ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$107M3172%N/AN/A
#2
$8.4M390%N/AN/A
#3
$26.7M9913%N/AN/A
#4
$24.3M900%N/AN/A
#5
$69.5M234-4%N/AN/A
#6
$4.3M23-12%N/AN/A
#7
$50.5M1708%N/AN/A
#8
$57.9M1958%N/AN/A
#9
$29.2M108-4%N/AN/A
#10
$213M63123%N/AN/A
Add Company

What Is TMS Neuro Solutions?

TMS Neuro Solutions, LLC (TMSNS) was formed in September 2011 as a turn-key solution for doctors for the treatment of Major Depressive Disorder (MDD) utilizing TMS Therapy. Our mission is to be a key player in fighting the United States suicide epidemic by fixing the delivery model of behavioral health. TMSNS embraces the concept of best practice process management and actively seeks out opportunities to integrate local improvements into the operational model to be used across the network. At TMS Neuro Solutions, we utilize proven, state-of-the-art treatments to treat psychiatric and neurological disorders. Our main form of treatment is TMS therapy, but every patient we treat receives a personalized plan of care that may incorporate cognitive behavioral therapy, diet, and exercise. Our treatments have proven to be effective for patients who have had unsuccessful experiences treating depression and other psychiatric disorders. TMS therapy is approved by the FDA, has no long-term side effects, lasts for only 4 to 7 weeks, and does not require patients to recover after each session, meaning you can resume your normal schedule without interruption.

keywords:N/A

N/A

Total Funding

90

Number of Employees

$24.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TMS Neuro Solutions News

2022-04-17 - Transcranial Magnetic Stimulators Market Size, Scope And Forecast ...

... Scope And Forecast | eNeura BrainsWay Ltd., MagVenture, Nexstim Plc, TMS Neuro Solutions, Magstim, Neuronetics Beckman Coulter, Inc.

2022-04-13 - Transcranial Magnetic Stimulators Market Size And Forecast ...

... Size And Forecast | eNeura BrainsWay Ltd., MagVenture, Nexstim Plc, TMS Neuro Solutions, Magstim, Neuronetics Beckman Coulter, Inc.

2019-09-02 - Transcranial Magnetic Stimulator Market Analysis 2019 ...

By Leading manufacturers: Axilum Robotics, Mastigm, Nexstim plc, Neuronetics Inc., Brainsway Ltd., TMS Neuro Solutions. By Product Types: ...

2019-08-23 - Transcranial Magnetic Stimulator- Global Competitive ...

Inclusive comprehension of Global Transcranial Magnetic Stimulator Market 2019 addressing structure, scope, potential, and growth prospects. The Global ...

2019-08-10 - Transcranial Magnetic Stimulator Market Sales Volume, Status ...

Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation which uses magnetic induction forces focusing on a particular area of the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.8M907%N/A
#2
$24.3M901%N/A
#3
$18.1M9029%N/A
#4
$13.5M907%N/A
#5
N/A9223%N/A